Revolution Medicines Inc (RVMD)
39.43
+0.44
(+1.13%)
USD |
NASDAQ |
May 17, 16:00
39.43
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Total Liabilities (Quarterly): 182.90M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 182.90M |
| December 31, 2023 | 235.51M |
| September 30, 2023 | 146.77M |
| June 30, 2023 | 142.87M |
| March 31, 2023 | 121.03M |
| December 31, 2022 | 126.74M |
| September 30, 2022 | 144.49M |
| June 30, 2022 | 133.96M |
| March 31, 2022 | 131.78M |
| December 31, 2021 | 135.42M |
| Date | Value |
|---|---|
| September 30, 2021 | 96.77M |
| June 30, 2021 | 89.04M |
| March 31, 2021 | 89.07M |
| December 31, 2020 | 92.72M |
| September 30, 2020 | 90.00M |
| June 30, 2020 | 93.46M |
| March 31, 2020 | 69.02M |
| December 31, 2019 | 67.99M |
| September 30, 2019 | 69.08M |
| December 31, 2018 | 73.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
67.99M
Minimum
Dec 2019
235.51M
Maximum
Dec 2023
118.88M
Average
121.03M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Cutera Inc | 504.56M |
| BioSig Technologies Inc | 4.685M |
| TRACON Pharmaceuticals Inc | 10.91M |
| Zentalis Pharmaceuticals Inc | 98.71M |
| Day One Biopharmaceuticals Inc | 29.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.908B |
| Shareholders Equity (Quarterly) | 1.725B |